Skip to content

Nasdaq · CIK 0001863127

TYRA Tyra Biosciences, Inc.

Insider trading from SEC Form 4. Last filing 25 d ago. Close $19.94 on Oct 9, 2026, +47% from the 52-week low and -50% from the high.

Last 90 days

Net insider value
+$20k
more bought than sold
Buys
1
$20k by 1 insider
Sells
0
$0 by 0 insiders
Insiders on file
8
with a Form 4 at this company

Price and insider trades, last year

TYRAOct 9, 2026 · close 19.94

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

Open-market buys and sells at Tyra Biosciences, Inc., scored.

ScoreInsiderValueHoldingsPrice contextFiled
31WeakRehan Verjee
director
buy
$20k
972 shares
-+86% from low-44% from high
23WeakNina S Kjellson
director
sell
$74k
5,401 shares
-0%-
24WeakNina S Kjellson
director
sell
$78k
4,825 shares
-0%-
31WeakNina S Kjellson
director
sell
$410k
25,041 shares
-1%-
24WeakNina S Kjellson
director
sell
$89k
5,272 shares
-0%-
51ModerateRa Capital Management, L.p.
director, owner
buy
$20M
1,220,681 shares
+16%-
40ModerateNina S Kjellson
director
sell
$1.3M
74,582 shares
-2%-
27WeakNina S Kjellson
director
sell
$194k
11,569 shares
-0%-
51ModerateAlan Fuhrman
Chief Financial Officer
buy
$152k
9,500 shares
+284%-
48ModerateNina S Kjellson
director
sell
$2.3M
138,711 shares
-4%-
38WeakTodd Harris
President and CEO
sell
$1.7M
62,720 shares
-4%-
30WeakTodd Harris
President and CEO
sell
$1.5M
58,726 shares
-4%-

Transactions

The last 49 rows filed, every code.

DateInsiderTransactionSharesPriceValueHoldings afterFiled
Sep 15, 2026Todd Harris
President and CEO
AGrant or award
Common Stock
+864$9.13$7,8871,438,49525 d ago
Sep 15, 2026Ra Capital Management, L.p.
director, owner
POpen-market purchase
Pre-Funded Warrants (Right to Buy)derivativeindirect: See footnotes
+9,078,529$22.03$200M11,616,98625 d ago
Sep 15, 2026Yuliya Rueb
Vice President, Finance (PAO)
AGrant or award
Common Stock
+2,925$9.13$27k11,25825 d ago
Sep 15, 2026Alan Fuhrman
Chief Financial Officer
AGrant or award
Common Stock
+951$9.13$8,68237,11525 d ago
Sep 9, 2026Rehan Verjee
director
POpen-market purchase
Common Stock
+972$20.58$20k97231 d ago
Mar 14, 2025Alan Fuhrman
Chief Financial Officer
AGrant or award
Common Stock
+1,238$9.78$12k14,087Mar 18, 2025
Mar 14, 2025Todd Harris
President and CEO
AGrant or award
Common Stock
+1,241$9.78$12k1,357,168Mar 18, 2025
Feb 5, 2025Nina S Kjellson
director
SOpen-market sale
Common Stockindirect: By Canaan XI L.P
-1,890$13.76$26k3,700,705Feb 7, 2025
Feb 5, 2025Nina S Kjellson
director
SOpen-market sale
Common Stockindirect: By 2020+ Co-Investment L.P. - Series 7
-3,511$13.76$48k443,885Feb 7, 2025
Jan 29, 2025Adele M. Gulfo
director
AGrant or award
Common Stock (Right to Buy)derivative
+37,200$0.00$037,200Jan 31, 2025
Jan 23, 2025Nina S Kjellson
director
SOpen-market sale
Common Stockindirect: By Canaan XI L.P
-4,825$16.26$78k3,702,595Jan 27, 2025
Jan 16, 2025Nina S Kjellson
director
SOpen-market sale
Common Stockindirect: By Canaan XI L.P.
-6,944$16.29$113k3,724,221Jan 21, 2025
Jan 16, 2025Nina S Kjellson
director
SOpen-market sale
Common Stockindirect: By 2020+ Co-Investment L.P. - Series 7
-835$16.29$14k447,857Jan 21, 2025
Jan 17, 2025Nina S Kjellson
director
SOpen-market sale
Common Stockindirect: By Canaan XI L.P.
-12,808$16.40$210k3,711,413Jan 21, 2025
Jan 17, 2025Nina S Kjellson
director
SOpen-market sale
Common Stockindirect: By 2020+ Co-Investment L.P. - Series 7
-461$16.40$7,560447,396Jan 21, 2025
Jan 21, 2025Nina S Kjellson
director
SOpen-market sale
Common Stockindirect: By Canaan XI L.P
-3,993$16.36$65k3,707,420Jan 21, 2025
Nov 25, 2024Nina S Kjellson
director
SOpen-market sale
Common Stockindirect: By Canaan XI L.P.
-4,706$16.84$79k3,731,165Nov 26, 2024
Nov 25, 2024Nina S Kjellson
director
SOpen-market sale
Common Stockindirect: By 2020+ Co-Investment L.P. - Series 7
-566$16.84$9,531448,692Nov 26, 2024
Nov 8, 2024Ra Capital Management, L.p.
director, owner
POpen-market purchase
Common Stockindirect: See footnotes
+1,220,681$16.25$20M8,697,956Nov 13, 2024
Nov 6, 2024Nina S Kjellson
director
SOpen-market sale
Common Stockindirect: By Canaan XI L.P.
-46,856$17.18$805k3,755,591Nov 8, 2024
Nov 6, 2024Nina S Kjellson
director
SOpen-market sale
Common Stockindirect: By 2020+ Co-Investment L.P. - Series 7
-5,635$17.18$97k451,629Nov 8, 2024
Nov 7, 2024Nina S Kjellson
director
SOpen-market sale
Common Stockindirect: By Canaan XI L.P.
-19,720$17.32$342k3,735,871Nov 8, 2024
Nov 7, 2024Nina S Kjellson
director
SOpen-market sale
Common Stockindirect: By 2020+ Co-Investment L.P. - Series 7
-2,371$17.32$41k449,258Nov 8, 2024
Nov 4, 2024Nina S Kjellson
director
SOpen-market sale
Common Stockindirect: By Canaan XI L.P.
-960$17.01$16k3,811,814Nov 6, 2024
Nov 4, 2024Nina S Kjellson
director
SOpen-market sale
Common Stockindirect: By 2020+ Co-Investment L.P. - Series 7
-116$17.01$1,973458,390Nov 6, 2024
Nov 5, 2024Nina S Kjellson
director
SOpen-market sale
Common Stockindirect: By Canaan XI L.P.
-9,367$16.77$157k3,802,447Nov 6, 2024
Nov 5, 2024Nina S Kjellson
director
SOpen-market sale
Common Stockindirect: By 2020+ Co-Investment L.P. - Series 7
-1,126$16.77$19k457,264Nov 6, 2024
Oct 30, 2024Alan Fuhrman
Chief Financial Officer
POpen-market purchase
Common Stock
+9,500$16.00$152k12,849Nov 1, 2024
Oct 30, 2024Nina S Kjellson
director
SOpen-market sale
Common Stockindirect: By Canaan XI L.P.
-9,889$16.17$160k3,926,706Nov 1, 2024
Oct 30, 2024Nina S Kjellson
director
SOpen-market sale
Common Stockindirect: By 2020+ Co-Investment L.P. - Series 7
-1,189$16.17$19k472,207Nov 1, 2024
Oct 31, 2024Nina S Kjellson
director
SOpen-market sale
Common Stockindirect: By Canaan XI L.P.
-89,390$16.46$1.5M3,837,316Nov 1, 2024
Oct 31, 2024Nina S Kjellson
director
SOpen-market sale
Common Stockindirect: By 2020+ Co-Investment L.P. - Series 7
-10,750$16.46$177k461,457Nov 1, 2024
Nov 1, 2024Nina S Kjellson
director
SOpen-market sale
Common Stockindirect: By Canaan XI L.P.
-23,938$16.54$396k3,813,378Nov 1, 2024
Nov 1, 2024Nina S Kjellson
director
SOpen-market sale
Commmon Stockindirect: By Canaan XI L.P.
-604$17.16$10k3,812,774Nov 1, 2024
Nov 1, 2024Nina S Kjellson
director
SOpen-market sale
Common Stockindirect: By 2020+ Co-Investment L.P. - Series 7
-2,878$16.54$48k458,579Nov 1, 2024
Nov 1, 2024Nina S Kjellson
director
SOpen-market sale
Common Stockindirect: By 2020+ Co-Investment L.P. - Series 7
-73$17.16$1,253458,506Nov 1, 2024
Oct 18, 2024Boxer Capital Management, LLC
other
DDisposition to issuer
Common Stockindirect: See footnote
-2,000,000--4,448,359Oct 22, 2024
Oct 18, 2024Ra Capital Management, L.p.
director, owner
JOther
Common Stockindirect: See footnotes
-1,000,000--7,477,275Oct 22, 2024
Oct 18, 2024Todd Harris
President and CEO
SOpen-market sale
Common Stock10b5-1
-43,636$27.01$1.2M1,375,011Oct 22, 2024
Oct 18, 2024Boxer Capital Management, LLC
other
AGrant or award
Pre-Funded Warrant (right to purchase)derivativeindirect: See footnote
+2,000,000--2,705,280Oct 22, 2024
Oct 21, 2024Todd Harris
President and CEO
SOpen-market sale
Common Stock10b5-1
-5,896$27.32$161k1,369,115Oct 22, 2024
Oct 21, 2024Todd Harris
President and CEO
SOpen-market sale
Common Stock10b5-1
-13,188$28.16$371k1,355,927Oct 22, 2024
Oct 18, 2024Ra Capital Management, L.p.
director, owner
JOther
Pre-Funded Warrants (Right to Buy)derivativeindirect: See footnotes
+2,358,457--1,000,000Oct 22, 2024
Oct 15, 2024Todd Harris
President and CEO
SOpen-market sale
Common Stock10b5-1
-10,035$24.31$244k1,467,338Oct 17, 2024
Oct 16, 2024Todd Harris
President and CEO
SOpen-market sale
Common Stock10b5-1
-4,900$25.22$124k1,462,438Oct 17, 2024
Oct 16, 2024Todd Harris
President and CEO
SOpen-market sale
Common Stock10b5-1
-24,475$26.23$642k1,437,963Oct 17, 2024
Oct 16, 2024Todd Harris
President and CEO
SOpen-market sale
Common Stock10b5-1
-3,922$26.98$106k1,434,041Oct 17, 2024
Oct 17, 2024Todd Harris
President and CEO
SOpen-market sale
Common Stock10b5-1
-15,194$25.84$393k1,418,847Oct 17, 2024
Oct 17, 2024Todd Harris
President and CEO
SOpen-market sale
Common Stock10b5-1
-200$26.37$5,2741,418,647Oct 17, 2024

Insiders

Everyone who has filed a Form 4 here.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

TYRA insider trading: Tyra Biosciences, Inc. | InsiderTell